Skip to main content

Zymeworks

Zymeworks Inc is a clinical-stage biopharmaceutical enterprise headquartered in Vancouver, Canada. The company specializes in the development of innovative bispecific antibody therapeutics for the treatment of cancer. Its proprietary Azymetric and EFECT platforms enable the engineering of multispecific therapeutic candidates targeting complex oncological indications. Principal revenue is currently earned through strategic pharmaceutical research partnerships, clinical development collaborations, and licensing agreements as its drug candidates advance through clinical trials. Zymeworks Inc is publicly listed on the New York Stock Exchange.

7 of the funds FundTelligence covers report a position in Zymeworks.

Legal name
ZYMEWORKS
Sector
Health Care
Country
United States
Funds holding it
7
Exposure themes
Cancer, Treatment, Women's Health

Funds holding Zymeworks

Loading...